ArticleMetabolomics : Official journal of the Metabolomic Society2025

MetabOCT: a clinical trial looking for a metabolomic signature predicting the onset of Leber's hereditary optic neuropathy in healthy MtDNA mutations carriers.

Christophe Orssaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.